Drug Patents owned by Primus Pharms

1. List of Impoyz drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9956231 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US10588914 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US10064875 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US9855334 PRIMUS PHARMS Topical compositions comprising a corticosteroid
Mar, 2035

(12 years from now)

Drugs and Companies using CLOBETASOL PROPIONATE ingredient

Market Authorisation Date: 28 November, 2017

Treatment: Treatment of moderate plaque psoriasis; Treatment of plaque psoriasis in patients 18 years of age or older; Psoriasis; Twice daily topical treatment of moderate to severe plaque psoriasis.; Treatment of plaque psoriasis; Plaque psoriasis; Treatment of moderate to severe plaque psoriasis in patients 18 years of age or older

Dosage: CREAM;TOPICAL

How can I launch a generic of IMPOYZ before it's patent expiration?
More Information on Dosage

2. List of Sernivo drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9439911 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US9775851 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US9364485 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US9655907 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US10179137 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US9433630 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US9877974 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

Drugs and Companies using BETAMETHASONE DIPROPIONATE ingredient

Market Authorisation Date: 05 February, 2016

Treatment: Treatment of plaque psoriasis

Dosage: SPRAY;TOPICAL

How can I launch a generic of SERNIVO before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in